Internal Medicine, Rheumatology · Covington, LA
NPI
1538566062
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1341 Ochsner Blvd
Covington, LA, 70433
Phone (985) 875-2828
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
537 services
Medicare patients, 2024
196
Average age 72
Drug cost, 2024
$6.8M
3,171 prescriptions
Company payments, 2025
$1,135
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Therese F Posas-Mendoza was code 99215 (office e&m - established), 254 times for 107 patients. In total Therese F Posas-Mendoza billed 537 services in 8 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 254 | 107 | $99.26 | $25K |
| 99214 Office E&M - Established | Office | 208 | 117 | $61.60 | $13K |
| 99205 Office E&M - New | Office | 27 | 27 | $116.56 | $3,147 |
| 20610 Joint Injection | Office | 23 | 15 | $37.59 | $864 |
By year: 2022 $21K for 260 services; 2023 $46K for 522 services; 2024 $43K for 537 services.
Medicare prescription drug claims, 2024
In 2024, the drug Therese F Posas-Mendoza prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 502 prescriptions and refills. In total Therese F Posas-Mendoza wrote 3,171 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 502 | 1,294 | 145 | $13K |
| Hydroxychloroquine Sulfate Generic | 382 | 1,072 | 120 | $13K |
| Prednisone Generic | 277 | 686 | 110 | $2,595 |
| Tramadol Hcl Generic | 207 | 222 | 57 | $964 |
| Orencia Clickject Abatacept | 204 | 209 | 30 | $1.2M |
| Humira(Cf) Pen Adalimumab | 176 | 182 | 26 | $1.6M |
| Alendronate Sodium Generic | 121 | 318 | 41 | $866 |
| Enbrel Sureclick Etanercept | 109 | 133 | 16 | $944K |
| Leflunomide Generic | 88 | 235 | 30 | $6,184 |
| Folic Acid Generic | 67 | 201 | 21 | $781 |
| Meloxicam Generic | 60 | 166 | 25 | $279 |
| Rinvoq Upadacitinib | 57 | 57 | Under 11 | $357K |
| Allopurinol Generic | 57 | 166 | 17 | $584 |
| Actemra Actpen Tocilizumab | 44 | 44 | Under 11 | $165K |
| Mycophenolate Mofetil Generic | 43 | 85 | 14 | $6,440 |
Brand drugs: - claims; generic drugs: 2,259 claims; opioid claims: 209.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Therese F Posas-Mendoza $1,135 ($1,135 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $347.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.